Precipio (PRPO) Profit After Tax Growth (3y) (2013 - 2025)
Precipio (PRPO) Profit After Tax Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.53% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -1.85% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -4.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 13.70% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 6.28% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.28% |
| 10 | Precipio | 36.29 Mn | 33.64 Mn | 3.13 Mn | 30.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.66% |
| Sep 30, 2025 | 70.80% |
| Jun 30, 2025 | 26.71% |
| Mar 31, 2025 | 42.23% |
| Dec 31, 2024 | 45.07% |
| Sep 30, 2024 | 30.37% |
| Jun 30, 2024 | 25.99% |
| Mar 31, 2024 | -12.74% |
| Dec 31, 2023 | 35.63% |
| Sep 30, 2023 | 23.83% |
| Jun 30, 2023 | -0.90% |
| Mar 31, 2023 | 1.85% |
| Dec 31, 2022 | 15.48% |
| Sep 30, 2022 | -18.70% |
| Jun 30, 2022 | 28.76% |
| Mar 31, 2022 | -40.52% |
| Dec 31, 2021 | 30.56% |
| Sep 30, 2021 | 21.61% |
| Jun 30, 2021 | -2.06% |
| Mar 31, 2021 | 15.90% |